|
WO2020028426A1
|
|
Diffusion enhancing compounds and their use with thrombectomy and embolectomy and other vascular disease procedures
|
|
JP2018135329A
|
|
Bipolar trans carotenoid salts and uses thereof
|
|
KR20190013715A
|
|
Use of bipolar transcarotenoids to treat cancer, chemotherapy and radiation therapy
|
|
JP2016183174A
|
|
Bipolar trans carotenoid salts and their use
|
|
JP2014144952A
|
|
Bipolar trans carotenoid salts and their uses
|
|
AU2011265546A1
|
|
Bipolar Trans Carotenoid Salts and Their Uses
|
|
AU2011262361A1
|
|
Oral formulations of bipolar trans carotenoids
|
|
KR20170109691A
|
|
Diffusion enhancing compounds and their use alone or with thrombolytics
|
|
JP2010090151A
|
|
Bipolar trans carotenoid salt and its use
|
|
BRPI0818119A2
|
|
A new class of therapeutic products that improve small molecule diffusion
|
|
EP3483140A1
|
|
Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease
|
|
KR20070106567A
|
|
Trans carotenoids, their synthesis, formulation and uses
|
|
CN102964238A
|
|
Bipolar trans-carotenoid salt and application thereof
|
|
US2004116729A1
|
|
Bipolar trans carotenoid salts and their uses
|
|
EP1667954A1
|
|
Bipolar trans carotenoid salts and their uses
|
|
PL373780A1
|
|
Bipolar trans carotenoid salts and their uses
|
